At meeting held on 19 May 2017
The Board of Directors of Camlin Fine Sciences at its meeting held on 19 May 2017 has approved to raise funds not exceeding Rs 250 crore by way of QIP/ GDR/ ADR/ FCCB/ other securities linked to equity/ preference shares/ convertible securities, subject to approval of shareholders. The Board has appointed Santosh Parab as CFO of the Company with effect from 10 May 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
